Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

CD29 Hamster anti-Rat, Brilliant Violet 421, Clone: Ha2/5, BD

Hamster Monoclonal Antibody

Manufacturer:  BD Biosciences 564131

Catalog No. BDB564131


Add to cart

Description

Description

The Ha2/5 monoclonal antibody specifically binds to the 130 kDa integrin β 1 chain (CD29). CD29 is expressed on the cell surface as a heterodimer with one of the distinct integrin α chains. With α 1 through α 6 (CD49a through CD49f), it forms the VLA-1 through VLA-6 complexes, respectively, and with α V (CD51), it forms α V β

The antibody was conjugated to BD Horizon™ BV421 which is part of the BD Horizon Brilliant™ Violet family of dyes. With an Ex Max of 407-nm and Em Max at 421-nm, BD Horizon BV421 can be excited by the violet laser and detected in the standard Pacific Blue™ filter set (eg, 450/50-nm filter). BD Horizon BV421 conjugates are very bright, often exhibiting a 10 fold improvement in brightness compared to Pacific Blue conjugates.

Specifications

Specifications

CD29
Ha2/5
Brilliant Violet 421
Aqueous buffered solution containing BSA and ≤0.09% sodium azide.
Hamster
IgM, κ
RUO
Primary
Rat
Flow Cytometry
0.2mg/mL
Itgb1; Integrin β1 chain; Integrin beta-1; VLA-4 subunit beta
Affinity Purified
Rat glomerular epithelial cells
50μg
Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.
Monoclonal
Documents
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit